🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Microangiopathy

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA NCT05855083Phase 216 sites📍 San Diego📍 Gainesville📍 Boston Omeros Corporation · Tests: Biological: narsoplimab Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre NCT06759961n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Construction of a Database for TMA NCT05634928n/a1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: collection data Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients NCT07059026n/a1 site📍 Buenos Aires ITAC (Instituto de Trasplantes y Alta Complejidad) Safety and Efficacy of Eculizumab in High-risk TA-TMA NCT07707687Phase 28 sites📍 Changsha📍 Hangzhou📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Eculizumab Microangiopathy in Diabetes NCT07145567n/a1 site📍 Danderyd Karolinska Institutet Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy NCT07347990NA1 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: iptacopan Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS NCT05795140Phase 39 sites📍 São Paulo📍 Rio de Janeiro📍 Beijing Novartis Pharmaceuticals · Tests: Iptcaopan 200 mg Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) NCT05935215Phase 331 sites📍 Nanjing📍 Beijing📍 Beijing Novartis Pharmaceuticals · Tests: Iptacopan Italian iTTP Registry NCT06376786n/a1 site📍 Milan Fondazione Luigi Villa Atypical Hemolytic-Uremic Syndrome (aHUS) Registry NCT01522183n/a141 sites📍 Aurora📍 Washington D.C.📍 Gainesville Alexion Pharmaceuticals, Inc. Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy NCT06102694n/a1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System NCT04838249n/a1 site📍 Leipzig University of Leipzig Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center NCT07205861n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium NCT04745195n/a1 site📍 Maastricht Maastricht University Medical Center Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation NCT06715046n/a2 sites📍 Milan📍 Turin University of Turin, Italy · Tests: Sample collation for cfDNA methylation analysis, Sample collection for EV phenotype analysis National Registry of Rare Kidney Diseases NCT06065852n/a1 site📍 Bristol UK Kidney Association The MIND Study - Microangiopathy IN Diabetes NCT06989190n/a1 site📍 Stockholm HJN Sverige AB/Neko Health
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy